A clinical and economic evaluation of red blood cell transfusions in patients receiving cancer chemotherapy

International Journal of Technology Assessment in Health Care

Volumn 14, Issue 4, 1998, Pages 788-798

  Ortega, Ana ^a   Dranitsaris, George ^a   Puodziunas, Anitasha ^a  

^a Princess Margaret Hospital   (United States)

Author keywords

Anemia; Blood Transfusions; Cancer; Chemotherapy; Cisplatin; Costs

Indexed keywords

CISPLATIN;

ANEMIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MYELOMA; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 0032447156     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300012083     Document Type: Article

References (20)

1. Abels, R. I., Larholt, K. M., Krantz, K. D., & Bryant, E. C. Recombinant human erythropoietin (r-HuEPO) for the treatment of anemia of cancer. In M. J. Murphy, Jr. (ed.), Blood cell growth factors: Their present and future use in hematology and oncology. Proceedings of the Beijing Symposium. Cleveland, OH: Alpha Med Press, 1991, 121-141.
2. Abels, R., Larholt, K., Nelson, R., & Young, D. Risk of transfusion in small cell lung cancer patients receiving chemotherapy. Blood, 1994, 84(suppl.), 664a.
3. Aledort, L., & Mohandas, K. Transfusion requirements in patients with malignancy. Seminars in Hematology, 1996, 33(suppl. 1), 6-9.
4. Cantor, S. B., Hudson, D. V., Lichtiger, B., & Rubenstein, E. B. The costs of blood transfusion: A process flow analysis. Proceedings of the American Society of Clinical Oncology, 1996, 15, 325.
5. Case, D. C., Bukowski, R. M., Carey, R. W., et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. Journal of the National Cancer Institute, 1993, 85, 801-06.
6. Cazzola, M., Mercuriali, F., & Brugnara, C. Use of recombinant human erythropoietin outside the setting of uraemia. Blood, 1997, 89, 4248-67.
7. Denton, T. A., Diamond, G. A., Matloff, J. M., & Gray, R. J. Anemia therapy: Individual benefit and societal cost. Seminars in Oncology, 1994, 21(suppl. 3), 29-35.
8. Dillman, R. O., Barth, N. M., Nayak, S. K., et al. High-dose chemotherapy with autologous stem cell rescue in breast cancer. Breast Cancer Research and Treatment, 1996, 37, 277-89.
9. Doyle, C., Stockier, M., Pintilie, M., et al. Resource implications of palliative chemotherapy for ovarian cancer. Journal of Clinical Oncology, 1997, 15, 1000-07.
10. Expert Working Group. Guidelines for red blood cell and plasma transfusion for adults and children. Canadian Medical Association Journal, 1997, 156 (suppl. 11) S1-S24.
11. Feinstein, A. R. Multivariate analysis: An introduction. New Haven, CT: Yale University Press, 1996.
12. Galloway, G. Red cross blood shortage delays elective operations. The Globe and Mail, March 27, 1997, A11.
13. Glaspy, J., Bukowski, R., Steinberg, D., et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Journal of Clinical Oncology, 1997, 15, 1218-34.
14. Hesketh, P. J., Cooley, T. P., Finkel, H. E., Wright, J., & Henketh, A. M. Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluoracil, and mitomycin C. Cancer, 1988, 62, 1466.
15. Koeller, J. M., & Van Den Berg, C. Anemias. In L. Y. Young & M. A. Koda-Kimble (eds.), Applied Therapeutics. The clinical use of drugs. Vancouver: Applied Therapeutics Inc., 1995, 88-1-88-3.
16. Lee, G. R. The anemia of chronic disease. Seminars in Hematology, 1983, 20, 61-80.
17. Means, R. T., & Krantz, S. B. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood, 1992, 80, 1639-47.
18. Miller, C. B., Jones, R. J., Piantadosi, S., Abeloff, M. D., & Spivak, J. L. Decreased erythropoietin response in patients with the anemia of cancer. New England Journal of Medicine, 1990, 322, 168-992.
19. Mohandas, K., & Aledort, L. Transfusion requirements, risks, and costs for patients with malignancy. Transfusion, 1995, 35, 427-30.
20. Moliterno, A. R., & Spivak, J. L. Anemia in cancer. Hematology/Oncology Clinics of North America, 1995, 10, 345-63.